56 reports of this reaction
1.3% of all ALUMINUM HYDROXIDE reports
#17 most reported adverse reaction
ANAEMIA is the #17 most commonly reported adverse reaction for ALUMINUM HYDROXIDE, manufactured by Rugby Laboratories. There are 56 FDA adverse event reports linking ALUMINUM HYDROXIDE to ANAEMIA. This represents approximately 1.3% of all 4,296 adverse event reports for this drug.
Patients taking ALUMINUM HYDROXIDE who experience anaemia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ANAEMIA is a less commonly reported adverse event for ALUMINUM HYDROXIDE, but still significant enough to appear in the safety profile.
In addition to anaemia, the following adverse reactions have been reported for ALUMINUM HYDROXIDE:
The following drugs have also been linked to anaemia in FDA adverse event reports:
ANAEMIA has been reported as an adverse event in 56 FDA reports for ALUMINUM HYDROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ANAEMIA accounts for approximately 1.3% of all adverse event reports for ALUMINUM HYDROXIDE, making it a notable side effect.
If you experience anaemia while taking ALUMINUM HYDROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.